Evidence of an acinar response following treatment for exacerbation in adult patients with cystic fibrosis

Respiration

Volumn 87, Issue 6, 2014, Pages 492-498

  Vanderhelst, Eef ^a   De Meirleir, Liesbeth ^a   Schuermans, Daniel ^a   Malfroot, Anne ^a   Vincken, Walter ^a   Verbanck, Sylvia ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Adult cystic fibrosis; Infectious exacerbation; Lung clearance index; Ventilation heterogeneity

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CYSTIC FIBROSIS; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LUNG CLEARANCE; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VENTILATION; LUNG VENTILATION DISTRIBUTION; MULTIPLE BREATH WASHOUT; OBSERVATIONAL STUDY; PHYSIOTHERAPY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ACINAR LUNG ZONE; BODY MASS; BRONCHIECTASIS; FORCED VITAL CAPACITY; LUNG; MULTIPLE BREATH WASHOUT TEST; PANCREAS INSUFFICIENCY; TREATMENT RESPONSE; BELGIUM; BREATH ANALYSIS; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG EFFECTS; DRUG MONITORING; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; OUTCOME ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT ACUITY; PROCEDURES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADULT; ANTI-BACTERIAL AGENTS; BELGIUM; BREATH TESTS; CYSTIC FIBROSIS; DISEASE PROGRESSION; DRUG MONITORING; FEMALE; HUMANS; LUNG; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ACUITY; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84899779332     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000360772     Document Type: Article

References (24)

1. Clinical Practice Guidelines for Cystic Fibrosis. Bethesda, Cystic Fibrosis Foundation, 1997.
2. Cystic Fibrosis Foundation: UK Patient Registry Annual Report 2011. Bethesda, Cystic Fibrosis Foundation, 2011.
3. Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH: Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med 2010; 182: 627-632.
4. Robinson PD, Cooper P, Van Asperen P, Fitzgerald D, Selvadurai H: Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol 2009; 44: 733-742.
5. Horsley AR, Davies JC, Gray RD, Macleod KA, Donovan J, Aziz ZA, Bell NJ, Rainer M, Mt-Isa S, Voase N, Dewar MH, Saunders C, Gibson JS, Parra-Leiton J, Larsen MD, Jeswiet S, Soussi S, Bakar Y, Meister MG, Tyler P, Doherty A, Hansell DM, Ashby D, Hyde SC, Gill DR, Greening AP, Porteous DJ, Innes JA, Boyd AC, Griesenbach U, Cunningham S, Alton EW: Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 2013; 68: 532-539.
6. Becklake MR: A new index of the intrapulmonary mixture of inspired air. Thorax 1952; 7: 111-116.
7. Kraemer R, Blum A, Schibler A, Ammann RA, Gallati S: Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005; 171: 371-378. (Pubitemid 40223405)
8. Engel LA: Intraregional gas mixing and distribution; in Engel LA, Paiva M (eds): Gas Mixing and Distribution in the Lung. New York, Marcel Dekker, 1985, pp 287-358.
9. Larsson A, Jonmarker C, Werner O: Ventilation inhomogeneity during controlled ventilation: which index should be used? J Appl Physiol 1988; 65: 2030-2039. (Pubitemid 19012305)
10. Verbanck S, Schuermans D, Van Muylem A, Paiva M, Noppen M, Vincken W: Ventilation distribution during histamine provocation. J Appl Physiol 1997; 83: 1907-1916. (Pubitemid 28006490)
11. Hanon S, Verbanck S, Schuermans D, Vanden Berghe B, Vanderhelst E, Vincken W: Evidence of improved small airways function after azithromycin treatment in diffuse panbronchiolitis. Respiration 2012; 84: 75-79.
12. Vanderhelst E, Hanon S, Verbanck S, Schuermans D, Wissing K, Bonella F, Vincken W: Whole-lung lavage: a successful treatment for restoring acinar ventilation distribution in primary acquired pulmonary alveolar proteinosis. Respiration 2012; 84: 70-74.
13. Verbanck S, Paiva M, Paeps E, Schuermans D, Malfroot A, Vincken W, Vanderhelst E: Lung clearance index in adult CF patients: the role of convection-dependent lung units. Eur Respir J 2013; 42: 380-388.
14. Verbanck S, Paiva M, Schuermans D, Malfroot A, Vincken W, Vanderhelst E: Acinar and conductive ventilation heterogeneity in severe CF lung disease: back to the model. Respir Physiol Neurobiol 2013; 188: 124-132.
15. Fuchs SI, Toussaint S, Edlhaimb B, Ballmann M, Gappa M: Short-term effect of physiotherapy on variability of the lung clearance index in children with cystic fibrosis. Pediatr Pulmonol 2010; 45: 301-306.
16. Abbas C, Singer F, Yammine S, Casualta C, Latzin P: Treatment response of airway clearance assessed by single breath washout in children with cystic fibrosis. J Cyst Fibros 2013; 12: 567-574.
17. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968. (Pubitemid 41632054)
18. Robinson PD, Latzin P, Verbanck S, Hall GL, Horsley A, Gappa M, Thamrin C, Arets HG, Aurora P, Fuchs SI, King GG, Lum S, Macleod K, Paiva M, Pillow JJ, Ranganathan S, Ratjen F, Singer F, Sonnappa S, Stocks J, Subbarao P, Thompson BR, Gustafsson PM: Consensus statement for inert gas washout measurement using multiple-and single-breath tests. Eur Respir J 2013; 41: 507-522.
19. Verbanck S, Thompson BR, Schuermans D, Kalsi H, Biddiscombe M, Stuart-Andrews C, Hanon S, Van Muylem A, Paiva M, Vincken W, Usmani O: Ventilation heterogeneity in the acinar and conductive zones of the normal ageing lung. Thorax 2012; 67: 789-795.
20. Prisk GK, Elliott AR, Guy HJ, Verbanck S, Paiva M, West JB: Multiple breath wash in of helium and sulfur hexafluoride in sustained microgravity. J App Physiol 1998; 84: 244-252. (Pubitemid 28065135)
21. Verbanck S, Paiva M, Schuermans D, Hanon S, Vincken W, Van Muylem A: Relationships between the lung clearance index and conductive and acinar ventilation heterogeneity. J Appl Physiol 2012; 112: 782-790.
22. Gozal D, Bailey S, Keens T: Evolution of pulmonary function during an acute exacerbation in hospitalized patients with cystic fibrosis. Pediatr Pulmonol 1993; 16: 347-353.
23. Doring G, Flume P, Heijerman H, Elborn JS; Consensus Study Group: Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros 2012; 11: 461-479.
24. Thornton J, Elliott R, Tully MP, Dodd M, Webb AK: Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis. Thorax 2004; 59: 242-246. (Pubitemid 38339882)